Shares of Akso Health Group Sponsored ADR (NASDAQ:AHG - Get Free Report) saw unusually-high trading volume on Monday . Approximately 146,862 shares changed hands during trading, an increase of 114% from the previous session's volume of 68,563 shares.The stock last traded at $2.30 and had previously closed at $2.29.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of Akso Health Group in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Akso Health Group currently has a consensus rating of "Sell".
Check Out Our Latest Report on Akso Health Group
Akso Health Group Price Performance
The business has a fifty day moving average of $1.83 and a 200-day moving average of $1.64.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC bought a new position in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 16,748 shares of the company's stock, valued at approximately $27,000. 1.21% of the stock is currently owned by institutional investors and hedge funds.
About Akso Health Group
(
Get Free Report)
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Akso Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Akso Health Group wasn't on the list.
While Akso Health Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.